The Zomedica Solution

Zomedica is building a diversified portfolio of companion animal products to include innovative drugs, drug-delivery technologies, diagnostics and devices by focusing on the unmet needs of clinical veterinarians.

  • CORE PRODUCTS: Urgent & Pervasive Needs

    Developing FDA Center for Veterinary Medicine approved drug pipeline


    Targeting devices and diagnostics via collaborations, in-licensing and other strategic relationships

  • BLUE SKY: New Solutions

    Targeting early-stage discovery via R&D, in-licensing and other strategic relationships

  • The Zomedica Solution

Core Pipeline

Zomedica is developing a core drug pipeline of FDA Center for Veterinary Medicine (FDA-CVM) approved drugs that address the urgent and pervasive needs of clinical veterinarians. Disclosed products are identified below with other undisclosed therapeutics at various early-stages of development.



Complementary Diagnostics Pipeline

Zomedica has entered into a research collaboration agreement with Celsee Diagnostics, Inc., an innovator of human health products in the emerging field of liquid biopsy. The research project defined in the agreement aims to test the feasibility of Celsee’s liquid biopsy technology for veterinary application as a canine cancer diagnostic.